Small Molecules

29 Aug 2007 Allergan and Exonhit's first collaboration compound to begin human clinical trials
29 Aug 2007 Compugen Announces Agreement with Teva Covering Splice Variant of MCP1 for Treatment of Chronic Inflammatory Diseases
29 Aug 2007 FDA Accepts for Review Complete Response to Approvable Letter for Entereg(R) (alvimopan) for POI
29 Aug 2007 EPIX Pharmaceuticals Achieves Milestone in Collaboration with Cystic Fibrosis Foundation Therapeutics
29 Aug 2007 CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
29 Aug 2007 Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
29 Aug 2007 Medicis and Hyperion Therapeutics Announce Strategic Collaboration
29 Aug 2007 Indevus Announces Submission of New Drug Application
29 Aug 2007 Kythera Biopharmaceuticals initiates Phase II study of its adypolitic agent for reduction of submental fat
28 Aug 2007 Biomira initiates Phase 1 trial of PX-478 in patients with advanced metastatic cancers
28 Aug 2007 Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
28 Aug 2007 TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
28 Aug 2007 Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
27 Aug 2007 Rasilez(R) receives EU approval, the first major innovation in high blood pressure treatment for more than a decade
27 Aug 2007 Neurochem announces results from tramiprosate (ALZHEMED(TM)) North American Phase III clinical trial
25 Aug 2007 Approval of an additional dosage and administration for secondary eradication of Helicobacter pylori for proton pump inhibitors in Japan
24 Aug 2007 Aricept(R) Receives Approval for Additional Efficacy and Dosage
24 Aug 2007 GlaxoSmithKline Accelerates Review of Exelixis' XL880
24 Aug 2007 CollaGenex Pharmaceuticals Announces Highly Positive Results of Phase 2 Dose-Finding Trial of Col-118 for the Treatment of Erythema
24 Aug 2007 Targacept Announces Initiation of Phase IIb Development of AZD3480 (TC-1734) for Cognitive Deficits in Schizophrenia
24 Aug 2007 Basilea Announces Submission of Marketing Authorization Application for Ceftobiprole by Janssen-Cilag AG to Swiss Regulatory Authority
24 Aug 2007 AtheroGenics Announces First Patients Enrolled in ANDES Phase III Diabetes Clinical Trial
24 Aug 2007 Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
24 Aug 2007 Cannasat Therapeutics to Commence Phase 1 Study of CAT 310, a Potential Treatment for Neuropathic Pain
23 Aug 2007 Antisoma's ASA404 1800 mg/m2 lung cancer trial will report positive survival data

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up